167 related articles for article (PubMed ID: 23190286)
21. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
22. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
Tumay Y; Altun Y; Ekmekci K; Ozkul Y
Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
[TBL] [Abstract][Full Text] [Related]
23. Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy.
Huber-Mollema Y; Oort FJ; Lindhout D; Rodenburg R
Epilepsia; 2019 Jun; 60(6):1069-1082. PubMed ID: 31166022
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy.
Herzog AG; Drislane FW; Schomer DL; Pennell PB; Bromfield EB; Dworetzky BA; Farina EL; Frye CA
Neurology; 2005 Oct; 65(7):1016-20. PubMed ID: 16217052
[TBL] [Abstract][Full Text] [Related]
25. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
Kim JY; Lee HW
Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
[TBL] [Abstract][Full Text] [Related]
26. The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy.
Cho YW; Kim DH; Motamedi GK
Seizure; 2011 May; 20(4):336-9. PubMed ID: 21316267
[TBL] [Abstract][Full Text] [Related]
27. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
Ramey P; Osborn M; Abou-Khalil B
Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
[TBL] [Abstract][Full Text] [Related]
28. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
Rambeck B; Jürgens UH; May TW; Pannek HW; Behne F; Ebner A; Gorji A; Straub H; Speckmann EJ; Pohlmann-Eden B; Löscher W
Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
[TBL] [Abstract][Full Text] [Related]
29. Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks.
Xiao F; Caciagli L; Wandschneider B; Sander JW; Sidhu M; Winston G; Burdett J; Trimmel K; Hill A; Vollmar C; Vos SB; Ourselin S; Thompson PJ; Zhou D; Duncan JS; Koepp MJ
Epilepsia; 2018 Jul; 59(7):1362-1371. PubMed ID: 29897625
[TBL] [Abstract][Full Text] [Related]
30. Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine.
Saetre E; Abdelnoor M; Amlie JP; Tossebro M; Perucca E; Taubøll E; Anfinsen OG; Isojärvi J; Gjerstad L
Epilepsia; 2009 Aug; 50(8):1841-9. PubMed ID: 19400874
[TBL] [Abstract][Full Text] [Related]
31. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.
Helmstaedter C; Witt JA
Epilepsy Behav; 2010 May; 18(1-2):74-80. PubMed ID: 20462801
[TBL] [Abstract][Full Text] [Related]
32. Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.
Zuberi NA; Baig M; Bano S; Batool Z; Haider S; Perveen T
Neurosciences (Riyadh); 2017 Apr; 22(2):114-118. PubMed ID: 28416782
[TBL] [Abstract][Full Text] [Related]
33. Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy.
Eun SH; Eun BL; Lee JS; Hwang YS; Kim KJ; Lee YM; Lee IG; Lee M; Ko TS; Kim JT; Eom S; Kim HD
Brain Dev; 2012 Nov; 34(10):818-23. PubMed ID: 22521904
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological outcomes in newly diagnosed epilepsy.
Mohanraj R; Brodie MJ
Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
[TBL] [Abstract][Full Text] [Related]
35. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
37. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
[TBL] [Abstract][Full Text] [Related]
38. Cross-sensitivity of skin rashes with antiepileptic drug use.
Hirsch LJ; Arif H; Nahm EA; Buchsbaum R; Resor SR; Bazil CW
Neurology; 2008 Nov; 71(19):1527-34. PubMed ID: 18981374
[TBL] [Abstract][Full Text] [Related]
39. Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.
Gidal BE; Rutecki P; Shaw R; Maly MM; Collins DM; Pitterle ME
Epilepsy Res; 1997 Oct; 28(3):207-11. PubMed ID: 9332885
[TBL] [Abstract][Full Text] [Related]
40. No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children.
Eriksson AS; Boreus LO
Ther Drug Monit; 1997 Oct; 19(5):499-501. PubMed ID: 9357090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
